Skip to main content
. Author manuscript; available in PMC: 2014 Oct 9.
Published in final edited form as: Int J Cardiol. 2013 Jul 17;168(4):3982–3990. doi: 10.1016/j.ijcard.2013.06.089

Figure 2. Modulation of SkM oxidative stress markers by ERC in T2D/HF patients before and after treatment.

Figure 2

(A) Changes in glutathione levels vs. control. (B) Summary of changes observed in carbonylation (DNP) and nitrotyrosine residue formation (NO2Tyr) vs. control. (Control n=3, patients n=4, *p<0.05 vs. before, # vs. control).